Claims for Patent: 5,629,189

Summary for Patent: 5,629,189

Title:	DNA encoding human cytoplasmic Cu/Zn superoxide dismutase
Abstract:	Methods and compositions are provided for the production of human superoxide dismutase and a novel protocol for enhancing efficiency of expression. The gene encoding for human superoxide dismutase is isolated and inserted into a vector in conjunction with a synthetic linker which provides for enhanced efficiency in translation. E. coli strain D1210 (pSODX8) was deposited at the A.T.C.C. on Sep. 27, 1983 and given Accession No. 39453. Yeast strain 2150-2-3 (pC1/1GAPSOD) and E. coli strains D1210 (pSOD11) and D1210 (pS2OR) were deposited at the A.T.C.C. on May 9, 1984, and given Accession Nos. 20708, 39679 and 39,680, respectively.
Inventor(s):	Hallewell; Robert A. (San Francisco, CA), Mullenbach; Guy T. (Oakland, CA)
Assignee:	Chiron Corporation (Emeryville, CA)
Application Number:	08/213,573
Patent Claims:	1. An intron-free DNA molecule which comprises a coding sequence for human cytoplasmic Cu/Zn superoxide dismutase, said intron-free DNA molecule comprising a synthetic linker sequence that (a) encodes at least amino acids 1-9 of the amino acid sequence of human Cu/Zn superoxide dismutase and (b) comprises a DNA spacer sequence in a region between the ribosomal binding site and the first codon for said superoxide dismutase coding sequence, wherein said linker sequence is in reading frame with a cDNA fragment that encodes the remainder of the amino acid sequence of human cytoplasmic Cu/Zn superoxide dismutase, wherein the coding sequence of the DNA molecule comprises the following nucleotide sequence: 5'-ATG GCX ACX AAG GCT GTT TGT GTT TTG AAG GGT GAC GGC CCA GTT CAA GGT ATT ATT AAC TTC GAG CAG AAG GAA AGT AAT GGA CCA GTG AAG GTG TGG GGA AGC ATT AAA GGA CTG ACT GAA GGC CTG CAT GGA TTC CAT GTT CAT GAG TTT GGA GAT AAT ACA GCA GGC TGT ACC AGT GCA GGT CCT CAC TTT AAT CCT CTA TCC AGA AAA CAC GGT GGG CCA AAG GAT GAA GAG AGG CAT GTT GGA GAC TTG GGC AAT GTG ACT GCT GAC AAA GAT GGT GTG GCC GAT GTG TCT ATT GAA GAT TCT GTG ATC TCA CTC TCA GGA GAC CAT TGC ATC ATT GGC CGC ACA CTG GTG GTC CAT GAA AAA GCA GAT GAC TTG GGC AAA GGT GGAAAT GAA GAAAGT ACA AAG ACA GGA AAC GCT GGC AGT CGT TTG GCT TGT GGT GTA ATT GGG ATC GCC CAA TAA-3'; wherein GCX represents GCA or GCT; and ACX represents ACG. 2. A vector which comprises the intron-free DNA molecule of claim 1. 3. A plasmid which comprises the intron-free DNA molecule of claim 1. 4. A cell into which the intron-free DNA molecule of claim 1 been introduced. 5. A procaryotic cell according to claim 4. 6. A bacterial cell according to claim 5. 7. A eucaryotic cell according to claim 4. 8. The intron-free DNA molecule as claimed in claim 1, wherein the coding sequence of the DNA molecule encodes the following amino acid sequence: Ala Thr Lys Ala Val Cys Val Leu Lys Gly Asp Gly Pro Val Gln Gly Ile Ile Ash Phe Glu Gln Lys Glu Ser Asn Gly Pro Val Lys Val Trp Gly Ser Ile Lys Giy Leu Thr Glu Gly Leu His Gly Phe His Val His Glu Phe Gly Asp Asn Thr Ala Gly Cys Thr Ser Ala Gly Pro His Phe Asn Pro Leu Ser Arg Lys His Gly Gly Pro Lys Asp Glu Glu Arg His Val Gly Asp Leu Gly Asn Val Thr Ala Asp Lys Asp Gly Val Ala Asp Val Ser Ile Glu Asp Ser Val Ile Ser Leu Ser Gly Asp His Cys Ile Ile Gly Arg Thr Leu Val Val His Glu Lys Ala Asp Asp Leu Giy Lys Gly Gly Ash Glu Glu Ser Thr Lys Thr Gly Ash Ala Gly Ser Arg Leu Ala Cys Gly Val Ile Gly Ile Ala Gln. 9. A vector which comprises the intron-free DNA molecule of claim 8. 10. A plasmid which comprises the intron-free DNA molecule of claim 8. 11. A cell into which the intron-free DNA molecule of claim 8 has been introduced. 12. A procaryotic cell according to claim 11. 13. A bacterial cell according to claim 12. 14. A eucaryotic cell according to claim 11. 15. An intron-free double-stranded DNA molecule wherein one strand of the DNA molecule comprises a coding sequence for human cytoplasmic Cu/Zn superoxide dismutase, said one strand comprising a synthetic linker sequence that (a) encodes at least amino acids 1-9 of the amino acid sequence of human Cu/Zn superoxide dismutase and (b) comprises a DNA spacer sequence in a region between the ribosomal binding site and the first codon for said superoxide dismutase coding sequence, wherein said linker sequence is in reading frame with a cDNA fragment that encodes the remainder of the amino acid sequence of human cytoplasmic Cu/Zn superoxide dismutase, wherein the coding sequence of the DNA molecule comprises the following nucleotide sequence: 5'-ATG GCX ACX AAG GCT GTT TGT GTT TTG AAG GGT GAC GGC CCA GTT CAA GGT ATT ATT AAC TTC GAG CAG AAG GAA AGT AAT GGA CCA GTG AAG GTG TGG GGA AGC ATT AAA GGA CTG ACT GAA GGC CTG CAT GGA TTC CAT GTT CAT GAG TTT GGA GAT AAT ACA GCA GGC TGT ACC AGT GCA GGT CCT CAC TTTAAT CCT CTA TCC AGA AAA CAC GGT GGG CCA AAG GAT GAA GAG AGG CAT GTT GGA GAC TTG GGC AAT GTG ACT GCT GAC AAA GAT GGT GTG GCC GAT GTG TCT ATT GAA GAT TCT GTG ATC TCA CTC TCA GGA GAC CAT TGC ATC ATT GGC CGC ACA CTG GTG GTC CAT GAA AAA GCA GAT GAC TTG GGC AAA GGT GGA AAT GAA GAA AGT ACA AAG ACA GGA AAC GCT GGC AGT CGT TTG GCT TGT GGT GTA ATT GGG ATC GCC CAA TAA-3'; wherein GCX represents GCA or GCT; and ACX represents ACG. 16. A vector which comprises the intron-free DNA molecule of claim 15. 17. A plasmid which comprises the intron-free DNA molecule of claim 15. 18. A cell into which the intron-fee DNA moleucle of claim 15 has been introduced. 19. A procaryotic cell according to claim 18. 20. A bacterial cell according to claim 19. 21. A eucaryotic cell according to claim 18. 22. The intron-free double-stranded DNA molecule as claimed in claim 15, wherein the coding sequence of the DNA molecule encodes the following amino acid sequence: Ala Thr Lys Ala Val Cys Val Leu Lys Gly Asp Gly Pro Val Gln Gly Ile Ile Asn Phe Glu Gln Lys Glu Ser Ash Gly Pro Val Lys Val Trp Gly Ser Ile Lys GIy Leu Thr Glu Gly Leu His Gly Phe His Val His Glu Phe Gly Asp Asn Thr Ala Giy Cys Thr Ser Ala Gly Pro His Phe Asn Pro Leu Ser Arg Lys His Gly Gly Pro Lys Asp Glu Glu Arg His Val Gly Asp Leu Gly Asn Val Thr Ala Asp Lys Asp Gly Val Ala Asp Val Ser Ile Glu Asp Ser Val Ile Ser Leu Ser Gly Asp His Cys Ile Ile Gly Arg Thr Leu Val Val His Glu Lys Ala Asp Asp Leu Giy Lys Gly Gly Asn Glu Glu Ser Thr Lys Thr Gly Asn Ala Gly Ser Arg Leu Ala Cys Gly Val Ile Gly Ile Ala Gln. 23. A vector which comprises the intron-free DNA molecule of claim 22. 24. A plasmid which comprises the intron-free DNA molecule of claim 22. 25. A cell into which the intron-free DNA molecule of claim 22 has been introduced. 26. A procaryotic cell according to claim 25. 27. A bacterial cell according to claim 26. 28. A eucaryotic cell according to claim 25.

Details for Patent 5,629,189

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2014-05-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2014-05-13
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2014-05-13